|
1
|
Jemal A, Murray T, Ward E, et al: Cancer
statistics, 2005. CA Cancer J Clin. 55:10–30. 2005.
|
|
2
|
Gridelli C, Rossi A and Maione P:
Treatment of non-small-cell lung cancer: state of the art and
development of new biologic agents. Oncogene. 22:6629–6638.
2003.
|
|
3
|
Stewart DJ: Tumor and host factors that
may limit efficacy of chemotherapy in non-small cell and small cell
lung cancer. Crit Rev Oncol Hematol. 75:173–234. 2010.
|
|
4
|
Chen CH, Lai JM, Chou TY, et al: VEGFA
upregulates FLJ10540 and modulates migration and invasion of lung
cancer via PI3K/AKT pathway. PLoS One. 4:e50522009.
|
|
5
|
Ogawa E, Takenaka K, Katakura H, et al:
Perimembrane Aurora-A expression is a significant prognostic factor
in correlation with proliferative activity in non-small-cell lung
cancer (NSCLC). Ann Surg Oncol. 15:547–554. 2008.
|
|
6
|
Rachet B, Woods LM, Mitry E, et al: Cancer
survival in England and Wales at the end of the 20th century. Br J
Cancer. 99(Suppl 1): S2–S10. 2008.
|
|
7
|
Ciardiello F, De Vita F, Orditura M and
Tortora G: The role of EGFR inhibitors in nonsmall cell lung
cancer. Curr Opin Oncol. 16:130–135. 2004.
|
|
8
|
Pao W, Miller V, Zakowski M, et al: EGF
receptor gene mutations are common in lung cancers from ‘never
smokers’ and are associated with sensitivity of tumors to gefitinib
and erlotinib. Proc Natl Acad Sci USA. 101:13306–13311. 2004.
|
|
9
|
Fiala O, Pešek M, Fínek J, et al: EGFR
mutations in patients with advanced NSCLC. Klin Onkol. 25:267–73.
2012.(In Czech).
|
|
10
|
de Mello RA, Pires FS, Marques DS, et al:
EGFR exon mutation distribution and outcome in non-small-cell lung
cancer: a Portuguese retrospective study. Tumour Biol.
33:2061–2068. 2012.
|
|
11
|
Hu C, Liu X, Chen Y, et al: Direct serum
and tissue assay for EGFR mutation in non-small cell lung cancer by
high-resolution melting analysis. Oncol Rep. 28:1815–1821.
2012.
|
|
12
|
Brambilla E, Travis WD, Colby TV, Corrin B
and Shimosato Y: The new World Health Organization classification
of lung tumours. Eur Respir J. 18:1059–1068. 2001.
|
|
13
|
Uramoto H and Mitsudomi T: Which biomarker
predicts benefit from EGFR-TK I treatment for patients with lung
cancer? Br J Cancer. 96:857–863. 2007.
|
|
14
|
Jackman DM, Yeap BY, Sequist LV, et al:
Exon 19 deletion mutations of epidermal growth factor receptor are
associated with prolonged survival in non-small cell lung cancer
patients treated with gefitinib or erlotinib. Clin Cancer Res.
12:3908–3914. 2006.
|
|
15
|
Riely GJ, Pao W, Pham D, et al: Clinical
course of patients with non-small cell lung cancer and epidermal
growth factor receptor exon 19 and exon 21 mutations treated with
gefitinib or erlotinib. Clin Cancer Res. 12:839–844. 2006.
|
|
16
|
Mitsudomi T, Kosaka T, Endoh H, et al:
Mutations of the epidermal growth factor receptor gene predict
prolonged survival after gefitinib treatment in patients with
non-small cell lung cancer with postoperative recurrence. J Clin
Oncol. 23:2513–2520. 2005.
|
|
17
|
Paez JG, Jänne PA, Lee JC, et al: EGFR
mutations in lung cancer: correlation with clinical response to
gefitinib therapy. Science. 304:1497–1500. 2004.
|
|
18
|
Kosaka T, Yatabe Y, Endoh H, et al:
Mutations of the epidermal growth factor receptor gene in lung
cancer: biological and clinical implications. Cancer Res.
64:8919–8923. 2004.
|
|
19
|
Huang SF, Liu HP, Li LH, et al: High
frequency of epidermal growth factor receptor mutations with
complex patterns in non-small cell lung cancers related to
gefitinib responsiveness in Taiwan. Clin Cancer Res. 10:8195–8203.
2004.
|
|
20
|
Marchetti A, Martella C, Felicioni L, et
al: EGFR mutations in non-small cell lung cancer: analysis of a
large series of cases and development of a rapid and sensitive
method for diagnostic screening with potential implications on
pharmacologic treatment. J Clin Oncol. 23:857–865. 2005.
|
|
21
|
Tokumo M, Toyooka S, Kiura K, et al: The
relationship between epidermal growth factor receptor mutations and
clinicopathologic features in non-small cell lung cancers. Clin
Cancer Res. 11:1167–1173. 2005.
|
|
22
|
Toyooka S, Matsuo K, Shigematsu H, et al:
The impact of sex and smoking status on the mutational spectrum of
epidermal growth factor receptor gene in non small cell lung
cancer. Clin Cancer Res. 13:5763–5768. 2007.
|
